Medical Biotechnology

Platform Enhances Purity and Reproducibility of Extracellular Vesicle Proteomics

Low-cost, high-throughput method improves purity and reproducibility of EV-based proteomics

Belgian researchers identify new antibodies against current and future coronaviruses

Blocking chemokine receptor increases effectiveness of glucocorticoids in multiple myeloma treatment

Inhibiting CCR1 can reverse glucocorticoid resistance, offering a new strategy to improve myeloma treatment

Scientists discover viral trapdoor blocking HIV and herpes

Flemish researchers launch OPENPichia, an industrial open access yeast system for the production of proteins

The system has applications in the production of medicines, and edible and industrial proteins, offering a cheaper and qualitative alternative to existing commercial variants

VIB and Ghent University develop new mRNA vaccines against bacterial infections

Vaccine consortium Baxerna doubles down on antimicrobial resistance

mRNA vaccines against bacteria: Listeria shows the way

The development of a Listeria vaccine opens a route to producing mRNA vaccines against other bacterial infections.

All in the game: VIB-UGent researchers enlist virtual space explorers to improve disease diagnostics

By harnessing the power of thousands of gamers, the team of Prof. Lennart Martens (VIB-UGent Center for Medical Biotechnology), with colleagues of Dhaenes lab of the Faculty of Pharmaceutical Sciences at Ghent University, intends to improve the analysis of mass spectrometry data drastically. In turn, this may advance disease diagnostics.

Digging for brain disease biomarkers with innovative proteomics

Two VIB research teams join forces to look for biomarkers in blood and cerebrospinal fluid samples of people living with frontotemporal degeneration.